Session 3: Advances in Organ-on-Chip Platforms

Chair: Rhiannon David, Ph.D. (AstraZeneca)

Organs-on-chips enable precise control of the cellular microenvironment providing improved in vivo relevance of in vitro cultures. Typically, these models are low throughput and analysis is done via off-chip analytical techniques and assays. This session will highlight advances in miniaturization, automation and integration of in situ analysis methods on-chip, which can accelerate and enhance the information that can be obtained from these organ chips.

Speakers:

Sensors in Microfluidic Organs-on-Chips
Róisín Owens, Ph.D. (University of Cambridge)

Scalable, Automated Immunotherapeutic and Cardiac Applications of Body on a Plate
Mark Lyons, Ph.D. (Hooke Bio)

h-VIOS: A Human-Relevant Drug Discovery and Development Platform Using Bioprinted Human Tissues
Taci Pereira (Systemic Bio)